← Leaderboards
Abenaa M Brewster
University Of Tx Md Anderson Can Ctr
$1,367,215
Attributed
$3,620,140
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $665.8K · FY2006–17$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$3,620,140 · 3
By mechanism
R01$3,100,605 · 1
R21$371,710 · 1
R03$147,825 · 1
Top collaborators
- Melissa L Bondy5 shared
- Patricia Ann Thompson-Carino5 shared
- Patricia A Parker2 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Wendy A Woodward$3,444,065
- Cielito C Reyes-Gibby$3,873,330
- Paul A Scheet$7,895,863
- James Martin Reuben$2,326,772
- Khandan Keyomarsi$13,000,468
Others in their field
Top investigators on “Recurrence”
- Philip J Disaia · University Of California Irvine$95,481,777
- David Heimbrook · Leidos Biomedical Research, Inc.$87,033,539
- Wafaa M. El-Sadr · Columbia University Health Sciences$84,793,830
- Myron S Cohen · Family Health International$84,793,830
- Lawrence Corey · Fred Hutchinson Cancer Center$59,594,035
- Dan H. Barouch · Fred Hutchinson Cancer Center$59,594,035
Research focus
RecurrenceMalignant NeoplasmsFollow-UpBaseDecision MakingMalignant Breast NeoplasmStagingCancer RecurrenceDiagnosisPublic Health RelevancePublic Health Medicine (Field)TissuesPrognosticGenotypeFundingPrognostic FactorTumorFormalinDetectionAge Of OnsetExhibitsFreezingCalibrationEpidemiologic Factors
Grant awards (9)
Risk Prediction for ER Negative Breast Cancer Recurrence$593,132
R01 · FY2017 · CA
Risk Prediction for ER Negative Breast Cancer Recurrence$614,362
R01 · FY2016 · CA
Risk Prediction for ER Negative Breast Cancer Recurrence$624,192
R01 · FY2015 · CA
Risk Prediction for ER Negative Breast Cancer Recurrence$603,134
R01 · FY2014 · CA
Risk Prediction for ER Negative Breast Cancer Recurrence$665,785
R01 · FY2013 · CA
A Decision Making Framework for Contralateral Prophylactic Mastectomy$174,540
R21 · FY2011 · CA · contact PI
A Decision Making Framework for Contralateral Prophylactic Mastectomy$197,170
R21 · FY2010 · CA · contact PI
Insulin Resistance and Breast Cancer Outcome$72,825
R03 · FY2007 · CA · contact PI
Insulin Resistance and Breast Cancer Outcome$75,000
R03 · FY2006 · CA · contact PI